TABLE 4.

Association of Factors With Participants Asking a Provider to Remove Implant in 3 Districts of Senegala

AOR (95% CI)
(n=820b)
Age group, years
 18–24Reference
 25–340.72 (0.45, 1.14)
 35–49+0.65 (0.36, 1.17)
Education level
 NoneReference
 Primary/middle1.04 (0.67, 1.61)
 Secondary or higher0.74 (0.44, 1.24)
Religion
 ChristianReference
 Muslim1.51 (0.69, 3.30)
Parity
 0Reference
 1–20.56 (0.19, 1.66)
 3–40.41 (0.13, 1.28)
 5+0.34 (0.10, 1.19)
Fertility intentions
 Do not want more children/do not want to have children/unsureReference
 Want more children/want to have children1.24 (0.76, 2.04)
Wealth (urban score)
 Low (quintile 1–3)Reference
 Middle (quintile 4)0.89 (0.57, 1.40)
 High (quintile 5)1.03 (0.68, 1.56)
Previous use of current method0.74 (0.50, 1.11)
Partner knowledge of current method at time of insertion1.18 (0.74, 1.89)
Informed choice1.42 (1.03, 1.96)c
Received method wanted0.81 (0.45, 1.44)
Insertion was free0.76 (0.54, 1.07)
Informed method could be removed at any time1.00 (0.55, 1.81)
Experienced amenorrhea1.61 (1.12, 2.32)c
Experienced bleeding disturbances1.13 (0.81, 1.56)
Experienced shorter or reduced bleeding0.55 (0.33, 0.91)c
Experienced longer or heavier bleeding1.23 (0.87, 1.75)
Experienced weight gain0.94 (0.68, 1.30)
Experienced other side effectsd2.61 (1.89, 3.60)c
  • Abbreviations: AOR, adjusted odds ratio; CI, confidence interval.

  • a Data are from phone and in-person survey participants. Nonresponses varied across items; small amounts of data are missing.

  • b Sample size of implant users (n=1,362) is reduced to n=820 in the multivariable regression model due to missing data.

  • c Statistically significant (P≤.05).

  • d Other side effects include any mentioned non-bleeding side effects other than weight gain.